CClinicalTrials.gg
CompletedNCT00717301Updated Jun 12, 2015

S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury

An observational study in Traumatic Brain Injury, sponsored by University of Rochester. Completed at 6 sites in United States. Per ClinicalTrials.gov, last updated 2015-06-12.

Sponsored by University of Rochester · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,252
Sex
All
01

Study summary

The purpose of the study is to determine if a specific blood protein, S-100B, can help predict who will have a traumatic abnormality on head CT scan after a concussion. We will compare the levels of this protein in the subject's blood to the initial head CT scan and to how the subject is feeling one month after injury. We hope that the information we collect in this trial will help us determine who needs a head CT scan after a concussion and who may be more likely to have trouble recovering from a concussion.

Read the detailed description

The primary objective of this study is to determine the ability of a serum S-100B to predict traumatic abnormalities on brain CT scan after mild traumatic brain injury (mild TBI). The secondary objective is to determine the relationship between initial S-100B levels and cognitive outcome at one month.

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • TBI, traumatic brain injury, S100B, head CT scan
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 1,252 is above the median of 100 across 690 observational studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients presenting to Emergency Departments that are a part of the AHCC (Academic Health Center Consortium) and/or ERNES (Emergency Research Network of the Empire State) networks.

Inclusion criteria

  • Patients presenting with head trauma to any of the AHCC/ERNES EDs, meeting the following criteria will be eligible to participate:

    • Presence of mild TBI per study definition
    • Arrival at the ED within 4 hours of injury
    • ED workup includes a Head CT

(Controls are eligible if they present to the Outpatient Lab for routine bloodwork during enrollment hours)

Exclusion criteria

Exclusion Criteria:

  • Time of injury not able to be determined
  • Head CT not done as part of clinical emergency care
  • Incarcerated
  • Non-English or Spanish speakers
  • Absence of parent/guardian for minor subjects
  • Subject and/or parent/guardian do not have capacity to consent
  • Head injury due to birth trauma, anoxia, inflammatory, toxic, infectious or metabolic encephalopathies that are not complications of head trauma
  • Ischemic or hemorrhagic stroke without associated trauma

(Controls are excluded if they have any of the following:History of brain tumor, melanoma and/or Alzheimer's disease; History of concussion, bone fracture or stroke (CVA or TIA) in the past month; History of surgery in the past month; Inability to obtain consent from subject and/or parent due to lack of capacity or absence of parent/guardian of minor; Inability to speak or read English; Incarceration)

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,252 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • Head Trauma

    Patients presenting to any of the AHCC/ERNES Emergency Departments with head trauma.

  • Control subjects

    Patients presenting to the Univ of Rochester Medical Center/Strong Memorial Hospital Outpatient Laboratory for routine blood draw.

06

What researchers measure

Primary outcomes

  1. Head CT scan

    Time frame: At time of injury in ED

Secondary outcomes

  1. Post concussive symptoms

    Time frame: One month after injury

07

Study locations

6 sites
  • Albany Medical College
    Albany, New York 12208, United States
  • Erie County Medical Center
    Buffalo, New York 14215, United States
  • Bassett Healthcare
    Cooperstown, New York 13326, United States
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
  • SUNY Upstate Medical Center at Syracuse
    Syracuse, New York 13210, United States
  • Guthrie
    Sayre, Pennsylvania 18840, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00717301
Lead sponsor
University of Rochester
Collaborators
Academic Health Center Consortium (not Univ of Minnesota), New York State Department of Health, Emergency Research Network of the Empire State
Responsible party
Jeffrey Bazarian (Professor, University of Rochester) — Principal investigator
First posted
Jul 17, 2008
Start date
Sep 2008
Primary completion
Sep 2010
Completion
Sep 2010
Last update
Jun 12, 2015

Study contacts

Jeffrey J Bazarian, MD, MPH
principal investigator · University of Rochester

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion